Search for tag: "risk"

112 Media

01:06:26 Board of Visitors Audit Committee Board of Visitors Audit Committee	Board of Visitors Audit Committee Board of Visitors Audit Committee from May 11th, 2023 audit lot compliance student questions risk board committee athletes recommendations plan meeting question basketball statements culture session areas model warehouse From Taron James 7 plays 0
01:08:35 PHTX_400_Review_of_Respiratory_and_Reproductive_Ph… PHTX_400_Review_of_Respiratory_and_Reproductive_Pharmacology_KLN	PHTX_400_Review_of_Respiratory_and_Reproductive_Pharmacology_KLN phtx 400 estrogen progesterone cancer risk hormone asthma contraceptives receptors airways drugs glucocorticoids channels lungs term mucus egg follicle therapy function patients From Katherine Nicholson 7 plays 0
56:52 PHTX_400_Lecture_22_Reproductive_Pharmacology_S202… PHTX_400_Lecture_22_Reproductive_Pharmacology_S2022	PHTX_400_Lecture_22_Reproductive_Pharmacology_S2022 phtx 400 estrogen hormone progesterone therapy cancer contraceptives ovulation estrogens bone effects follicle levels pregnancy increase risk oocyte breast endometrium cycle contraception From Katherine Nicholson 1 plays 0
01:03:04 Basic Long Term Care for the New Infection… Basic Long Term Care for the New Infection Preventionist (Pt. 2) -- Burdsall	Basic Long Term Care for the New Infection Preventionist (Pt. 2) -- Burdsall infection prevention care infection prevention lot risk control things organisms term precautions residents equipment staff assessment hand person facility antibiotics thing infections From Lily Warden 5 plays 1 Data Classification CATEGORY I DATA
01:41:13 4.14.23 Winn CDA Webinar 4.14.23 Winn CDA Webinar	4.14.23 Winn CDA Webinar winncdacohort1 hazard survival ratio risk model test regression treatment groups log patients rank effect function event events age interaction variables beta From Katelyn Foster 9 plays 0
42:24 VIPTC Foundational Level-01: Overview of HAIs… VIPTC Foundational Level-01: Overview of HAIs & Infection Prevention	VIPTC Foundational Level-01: Overview of HAIs & Infection Prevention healthcare infection prevention infectious diseases infection care infections prevention patients hospital precautions catheter catheters recommendations programs patient rates pneumonia ventilator organisms risk ipc resistance From Lily Warden 4 plays 0 Data Classification CATEGORY I DATA
01:09:49 PHTX 400 Lecture 20 Li CV Pharmacology Part 2 PHTX 400 Lecture 20 Li CV Pharmacology Part 2	PHTX 400 Lecture 20 Li CV Pharmacology Part 2 phtx 400 patient blood oxygen heart risk drug supply bladder effect vessel atherosclerosis decrease patients symptoms factor pain disease enzyme level cholesterol From Katherine Nicholson 3 plays 0
03:00:21 3.31.23 Winn CDA Scholars Forum 3.31.23 Winn CDA Scholars Forum	3.31.23 Winn CDA Scholars Forum clinical trials winncda winncdacohort2 engagement patients medicine doctors clinicaltrialist trials drthings disparities careerdiversity faculty trial cancer study breast prevention treatment studies things risk lot analysis tamoxifen size population control dose stool sample From Nicholette Espinosa 7 plays 0
02:55:44 Winn CDA Cohort 2 Scholar Forum #9 (3/29/23) Winn CDA Cohort 2 Scholar Forum #9 (3/29/23)	Winn CDA Cohort 2 Scholar Forum #9 (3/29/23) The Robert A. Winn Diversity in Clinical Trials Award Program Winn Career Development Award (Winn CDA) Cohort 2 Scholar Forum #9 Date: 3/29/23 Topic: Statistical Methods in… clinical trials winncda winncdacohort2 engagement patients medicine doctors clinicaltrialist trials drthings disparities careerdiversity faculty study control disease question patient prevalence correlation variable risk rate trial alright questions point cohort paper studies survey outcome treatment From Nicholette Espinosa 7 plays 0
53:09 Board of Visitors Audit, Integrity and Compliance… Board of Visitors Audit, Integrity and Compliance Committee Meeting	Board of Visitors Audit, Integrity and Compliance Committee Meeting Board of Visitors Audit, Integrity and Compliance Committee Meeting from March 23rd, 2023 training compliance things lot areas risk board questions question units level merit practices vcu process bit access slide programs risks From Taron James 4 plays 0
02:42:11 Winn CDA Cohort 2 Scholar Forum #7 (3/1/23) Winn CDA Cohort 2 Scholar Forum #7 (3/1/23)	Winn CDA Cohort 2 Scholar Forum #7 (3/1/23) The Robert A. Winn Diversity in Clinical Trials Award Program Winn Career Development Award (Winn CDA) Cohort 2 Scholar Forum #7 Date: 3/1/23 Topic: Epidemiology Presented by: Dr.… clinical trials winncda winncdacohort2 engagement patients medicine doctors clinicaltrialist trials drthings disparities careerdiversity faculty disease study risk person outcome exposure cases incidence population individuals studies odds epidemiology things measures cohort period prevalence outcomes rate From Nicholette Espinosa 13 plays 0
01:50:21 PHAR 621 Pharmacoeconomics PHAR 621 Pharmacoeconomics	PHAR 621 Pharmacoeconomics p3 sop pharmacy care patients standard analysis icer cost omalizumab lifetime horizon quality outcomes population costs hospitalizations risk effectiveness lot baseline reduction question From VCU PHARCAPTURE 90 plays 0
47:32 Palliative ECHO: Neuroleptic Malignant Syndrome… Palliative ECHO: Neuroleptic Malignant Syndrome (Feb. 2023)	Palliative ECHO: Neuroleptic Malignant Syndrome (Feb. 2023) Palliative Care ECHO: Sometimes it is a Zebra: Neuroleptic Malignant Syndrome in Palliative Care \| February 22, 2023 Presented by: Eashwar Swamy, MD VCU Health Palliative Medicine Fellow … palliative care palliative medicine end of life care symptoms patient nms things dose point neuroleptics haldol thing medications risk period delirium feedback treatment effect rigidity muscle lot unit From Teri Dulong-Rae 1 plays 0
20:00 Frances Eval Debrief Group 2 Room 3 Frances Eval Debrief Group 2 Room 3	Frances Eval Debrief Group 2 Room 3 occt721 things safety thing point questions tactile piece cues risk bed person lot cue room sink stuff end francis interaction walker From Carole Ivey 2 plays 0
02:24:39 Winn CDA Cohort 2 Scholar Forum #5 (2/1/23) Winn CDA Cohort 2 Scholar Forum #5 (2/1/23)	Winn CDA Cohort 2 Scholar Forum #5 (2/1/23) Robert A. Winn Diversity in Clinical Trials Award Program: Career Development Award (Winn CDA)Cohort 2Scholar Forum #5Date: 2/1/23Topic: Human Subjects ResearchPresented by: Todd W. Rice, MD,… clinical trials winncda winncdacohort2 engagement patients medicine doctors clinicaltrialist trials drthings disparities careerdiversity faculty careerdevelopmentaward irb study consent risk thing trial vanderbilt participants child approval things bit category question person lot patient studies stuff From Nicholette Espinosa 10 plays 0
42:24 VIPTC Foundational Level-01: Overview of HAIs… VIPTC Foundational Level-01: Overview of HAIs & Infection Prevention	VIPTC Foundational Level-01: Overview of HAIs & Infection Prevention Overview of HAIs & Infection Prevention, Presented by Barry Rittmann, MD, MPH, VIPTC's Infection Prevention & Control Foundational Level viptc infection prevention infections infection care prevention patients hospital precautions catheter catheters recommendations programs patient rates pneumonia ventilator organisms risk ipc healthcare resistance From Jo Dee Armstrong-Novak 4 plays 0